Systemic treatment in patients with malignant pleural mesothelioma – real life experience
Systemic treatment in patients with malignant pleural mesothelioma – real life experience
Malignant pleural mesothelioma (MPM) is a rare, aggressive malignancy of the pleural cavity linked to asbestos exposure. The combination of pemetrexed and platinum is a standard first-line therapy for malignant pleural mesothelioma. Despite some progress, almost all MPM patients experience progression after first-line therapy.